Soluble fms-like tyrosine kinase-1 (sFlt-1) contributes to pre-eclampsia pathogenesis by binding and neutralising which two angiogenic factors, thereby causing widespread endothelial dysfunction?
- A VEGF and PlGF ✓
- B VEGF and angiopoietin-1
- C PlGF and TGF-β1
- D EGF and FGF
Explanation
sFlt-1 is a truncated, soluble decoy receptor for VEGF (vascular endothelial growth factor) and PlGF (placental growth factor). It is released excessively by the hypoxic placenta in pre-eclampsia, sequesters free VEGF and PlGF in the maternal circulation, and prevents their binding to endothelial receptors — causing vasoconstriction, proteinuria, and the systemic features of pre-eclampsia. The sFlt-1:PlGF ratio >38 has high negative predictive value for ruling out pre-eclampsia within one week.
Reference: Williams Obstetrics, 26th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.